As HIV continues to cause substantial mortality and morbidity, with over a million people newly infected in Africa each year, LSTM has seen an expansion in the extent and scope of HIV-related research. 

The HIV research portfolio now spans studies on HIV-prevention to comprehensive, integrated care for people living with HIV to management of late-stage HIV-infection. This research is leading to measurable positive impacts which are at the cutting edge of improved HIV care in Africa: preventing infections, saving lives and increasing the health and well-being of those affected.